Výsledky vyhledávání - "Abdelhamid M. Fouad"

CLO20-046: National Cancer Institute Experience With Generic Anastrozole (Anastrodex, Hikma) in Newly Diagnosed Postmenopausal Female Egyptian Patients With Low Burden Visceral Metastatic Breast Cancer

Autor: Abdelhamid M. Fouad, Mohamed Maher, Mariam Maged Elhaddad

Publikováno v: Journal of the National Comprehensive Cancer Network. 18:CLO20-046

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5718289ecc6d836b745e1250ae4d4cf2
https://doi.org/10.6004/jnccn.2019.7398

Zobrazit plný text záznamu

Treatment Outcome of Pharmacokinetics-Based Dosing of Docetaxel and Fluorouracil in Advanced Head and Neck Cancer Patients

Autor: Reham A. A. Elshimy, Magdy M. Saber, Tarek M. Shouman, Abdelhamid M. Fouad, Ahmed Abo Gabal, Yasser A. Sallam, Yahia M. Ismail

Publikováno v: Journal of Cancer Therapy. :998-1010

Introduction: Docetaxel, Cisplatin and 5-Fluorouracil (DPF) became the standard induction chemotherapy in advanced Head and Neck Cancer (HNC) but associated with high toxicity rate. Several studies reported higher response rates with better tolerabil

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3ba051b0b5329b192062fff8acc634f8
https://doi.org/10.4236/jct.2018.912082

Zobrazit plný text záznamu

Pharmacokinetic-Based Chemotherapy Dosing in Advanced Head and Neck Cancer: A Mini Review

Autor: Abdelhamid M. Fouad, Ahmed Abo Gabal, Mariam Maged Elhaddad

Publikováno v: Research in Oncology, Vol 15, Iss 1, Pp 35-37 (2019)

Despite the continuous evolution in different treatment modalities for head and neck cancer (HNC), severe side effects of medications remain a challenge. Chemotherapy (CTH)-induced toxicities may lead to alterations in the treatment plan in the form

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd5700daf39cea8c814b272b5bbc91d7
https://doi.org/10.21608/resoncol.2019.10154.1074

Zobrazit plný text záznamu

MM-024: An Attempt to Overcome the Financial Toxicity of Targeted Agents, Single-Center Experience with Bendamustine vs Melphalan-Steroids Post Bortozomib or Lenalidomide Containing Regimens in R/R MM

Autor: Abdelhamid M. Fouad, Mohamed G. Shouman, Mohamed Maher

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 21:S417

Context Relapsed refractory multiple myeloma remains a critical medical scenario especially in transplant ineligible patients and in countries where the new approved targeted agents as anti-CD38 monoclonal antibodies or histone deacetylase (HDAC) inh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f1bf5e041d8521f33e76a846e051117b
https://doi.org/10.1016/s2152-2650(21)01936-4

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání